McKesson Corp. (0JZU) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of McKesson Corp. $454, price $892, upside -49.1%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch McKesson Corp. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $119.22 – $989.31 · fair‑value band $334.71 – $573.69 · the $891.54 price screens above the $454.20 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow McKesson in your weekly email
Every Wednesday you see whether McKesson is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Show more
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Stock analysis
McKesson Corp. (0JZU) currently trades at $891.54, while our model-based Fair Value estimate is $454.20, 49.1% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $525.75 per share, and 0 of the 21 models we run sit above the $891.54 price.
Bear case: the Earnings-Based group reads lowest at $234.23, and 21 of the 21 models stay below the price. Evidence for this calculation is medium.
Scenario range: $334.71 (bear) to $573.69 (bull), the price of $891.54 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
McKesson Corp. reported revenue of $403B in FY2026 versus $264B in FY2022, a compound +11.2%/yr. Reported net income was $4.8B in FY2026, compounding +43.8%/yr from FY2022.
Key figures
Market cap $111B · P/E ratio 1.1 · P/S ratio 0.01 · EPS (TTM) $7.23 · Dividend yield 0.4% · Net margin 1.2% · Return on equity 14.0% · Return on assets (EBIT) 6.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 10% below its 52-week high and 23% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −40% fair-value upside, at −49%, 0JZU screens richer than that median.
Fair Value models
Bear $334.71Fair Value $454.20Bull $573.69
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then ($2.07 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.83/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+12.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.1%
Start year 2021 (pandemic). Over 10 years: +7.8% a year
Revenue growth 31 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.
+40.2%
Earnings growth per share plus dividend.
From 2015 to 2026, about 72% of the growth in earnings per share came from share buybacks, and equity is negative: the buybacks are partly paid with debt. That cannot be repeated indefinitely.
Earnings per share, growth per year+39.8%
Dividend (yield on the price)0.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.44.5% vs 14.8%, picking up
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.1% → 2%
2026 sits 53% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Start year 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes about as much growth as the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+12.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+6.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +9.8% a year for the price and +4.1% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Trading Companies & Distributors” was too small, so the broader sector is used.)Industrials · 5293 stocks
Beats the sector median on 3/8 measures
Overall it trails its sector peers.
Valuation
Quality Score63 · Top 25%
Fair Value upside−49.1% · Below median
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets5.0% · Above median
Net margin (TTM)1.2% · Below median
Operating margin (TTM)2.2% · Below median
Growth and dividend
Revenue growth6.0% · Below median
Dividend yield (TTM)0.4% · Bottom 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Industrials median · lower = cheaper
P/E (TTM)1.1× · Cheapest 25%
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 16
FUTURE (revenue growth)30· sector 36
PAST (return on equity)0· sector 29
HEALTH (low debt)0· sector 94
DIVIDEND (yield)7· sector 37
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "McKesson Corp. Fair Value". https://www.fairvalue-calculator.com/stock/0JZU
Frequently asked questions
Is McKesson Corp. (0JZU) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $454.20 versus a price of $891.54, about −49% upside (overvalued).
What is the fair value of 0JZU?
Our model-based fair value for McKesson Corp. is $454.20 (as of Sep 24, 2026), built from audited fundamentals. The current price: $891.54.
What is the quality score of 0JZU?
McKesson Corp. has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for McKesson Corp. (0JZU)?
Our model-based price target is the fair value of $454.20 (as of Sep 24, 2026) from 21 valuation models. Cautious scenario $334.71, optimistic scenario $573.69. It is a calculation from audited fundamentals, not an analyst target.
What is the McKesson Corp. stock forecast for 2026?
Our models put fair value at $454.20, about −49% upside versus a price of $891.54 (overvalued). Cautious scenario $334.71, optimistic scenario $573.69. The calculation is refreshed regularly with new filings.
What is the revenue of McKesson Corp. (0JZU)?
McKesson Corp. reported trailing-twelve-month revenue of about $403B (latest available figure, as of Sep 24, 2026).
Does McKesson Corp. pay a dividend?
McKesson Corp. currently shows a dividend yield of about 0.36% relative to its recent price (as of Sep 24, 2026).
What growth is priced into McKesson Corp. (0JZU)?
For today's price to be fair in a discounted-cash-flow model, McKesson Corp. would have to grow free cash flow by +12.4 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +11.1 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0JZU use?
Our models discount McKesson Corp. at 9.0 %: a base by market capitalisation (unknown), damped by beta 0.32, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For McKesson Corp. that is +12.4 % per year a year over ten years, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has McKesson Corp. (0JZU) delivered so far?
Over the past 5 years revenue at McKesson Corp. grew +11.1 % a year. The price currently implies +12.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of McKesson Corp. (0JZU) growing?
The median revenue growth in the sector is +7.2 % a year. That is the yardstick for the growth priced into McKesson Corp. (+12.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of McKesson Corp. (0JZU)?
The free-cash-flow yield on the price is 3.90 %: that much free cash flow McKesson Corp. produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of McKesson Corp. (0JZU)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For McKesson Corp. it is $454.20 per share (as of Sep 24, 2026), against a price of $891.54. It is the blended result of 21 valuation models (cash flow, earnings, asset, dividend).
Is McKesson Corp. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0JZU trades above its calculated fair value: price $891.54, fair value $454.20, a gap of about −49% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0JZU?
No. The price is what the market pays today ($891.54); the fair value is what the company's own numbers justify ($454.20). For McKesson Corp. the two are $437.34 per share apart. That gap is exactly why we show both numbers side by side.
How much is McKesson Corp. worth?
The market values McKesson Corp. at about $111B (market capitalisation, as of Sep 24, 2026). Per share that is $891.54; our models calculate a fair value of $454.20 per share.
What do the bullish and bearish scenarios say about 0JZU?
Our models span a range for McKesson Corp.: cautious scenario $334.71, base $454.20, optimistic $573.69 per share (as of Sep 24, 2026, price $891.54). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0JZU?
McKesson Corp. trades at a price-to-earnings ratio of 1.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $454.20 is built from several models across several years.
How solid is the balance sheet of McKesson Corp. (0JZU)?
Balance-sheet figures for McKesson Corp. (as of Sep 24, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is 0JZU from its 52-week high?
McKesson Corp. trades at $891.54, about 10% below its 52-week high of $989.31 and 23% above the low of $727.77 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $454.20 is for.
Which stocks are comparable to McKesson Corp.?
From the same area (Industrials) we also value 534755, SCTL, Contemporary Amperex Technology Co, Delta Electronics (Thailand) Public Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is McKesson Corp. stock attractive at the current price?
The data as of Sep 24, 2026: price $891.54, calculated fair value $454.20 (−49%), Quality Score 64/100, from 21 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0JZU calculated?
We run McKesson Corp. through 21 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $454.20, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. McKesson Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of McKesson Corp. (0JZU)?
The closing price on Oct 2, 2026 was $891.54. Our model-based fair value is $454.20, about −49% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with McKesson Corp. right now?
The price sits above even our optimistic bull case ($573.69). The favourable scenario is already priced in. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of McKesson Corp. (0JZU) come from?
Earnings per share at McKesson Corp. grew +9.3 % a year from 2015 to 2026. Broken into its drivers: revenue per share +14.5 %, EBIT margin −3.5 %, tax rate +1.2 %, residual (interest, one-offs) −2.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of McKesson Corp.
How large is the market capitalisation of McKesson Corp. (0JZU)?
The market capitalisation of McKesson Corp. is $111B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of McKesson Corp. (0JZU)?
The price-to-sales ratio of McKesson Corp. is 0.01 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of McKesson Corp. (0JZU)?
Earnings per share at McKesson Corp. are $7.23 (price ÷ EPS = P/E 1.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of McKesson Corp. (0JZU)?
The dividend yield of McKesson Corp. is 0.4% (payout 43.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of McKesson Corp. (0JZU)?
The net margin of McKesson Corp. is 1.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of McKesson Corp. (0JZU)?
The return on equity (ROE) of McKesson Corp. is 14.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of McKesson Corp. (0JZU)?
On an EBIT basis the return on assets of McKesson Corp. is 6.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of McKesson Corp. (0JZU)?
The operating margin of McKesson Corp. is 2.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at McKesson Corp. (0JZU)?
Revenue at McKesson Corp. is growing +6.0% versus a year earlier (3y avg +13.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at McKesson Corp. (0JZU)?
Earnings per share at McKesson Corp. are growing +37.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does McKesson Corp. (0JZU) carry?
The net debt of McKesson Corp. is $4.6B (fiscal year 2026, ≈ 0.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch McKesson Corp. in the live analysis
One click puts McKesson Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
